JP4616971B2 - １−アザビシクロアルカン化合物およびその医薬用途 - Google Patents

１−アザビシクロアルカン化合物およびその医薬用途 Download PDF

Info

Publication number
JP4616971B2
JP4616971B2 JP2000217709A JP2000217709A JP4616971B2 JP 4616971 B2 JP4616971 B2 JP 4616971B2 JP 2000217709 A JP2000217709 A JP 2000217709A JP 2000217709 A JP2000217709 A JP 2000217709A JP 4616971 B2 JP4616971 B2 JP 4616971B2
Authority
JP
Japan
Prior art keywords
azabicyclo
octane
benzo
thiophen
nicotinic receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000217709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002030084A5 (enExample
JP2002030084A (ja
Inventor
雅和 藤尾
謙二 橋本
二郎 片山
敦 沼田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Priority to JP2000217709A priority Critical patent/JP4616971B2/ja
Publication of JP2002030084A publication Critical patent/JP2002030084A/ja
Publication of JP2002030084A5 publication Critical patent/JP2002030084A5/ja
Application granted granted Critical
Publication of JP4616971B2 publication Critical patent/JP4616971B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000217709A 2000-07-18 2000-07-18 １−アザビシクロアルカン化合物およびその医薬用途 Expired - Fee Related JP4616971B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000217709A JP4616971B2 (ja) 2000-07-18 2000-07-18 １−アザビシクロアルカン化合物およびその医薬用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000217709A JP4616971B2 (ja) 2000-07-18 2000-07-18 １−アザビシクロアルカン化合物およびその医薬用途

Publications (3)

Publication Number Publication Date
JP2002030084A JP2002030084A (ja) 2002-01-29
JP2002030084A5 JP2002030084A5 (enExample) 2010-07-08
JP4616971B2 true JP4616971B2 (ja) 2011-01-19

Family

ID=18712778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000217709A Expired - Fee Related JP4616971B2 (ja) 2000-07-18 2000-07-18 １−アザビシクロアルカン化合物およびその医薬用途

Country Status (1)

Country Link
JP (1) JP4616971B2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
CZ2004408A3 (cs) 2001-10-02 2005-03-16 Pharmacia & Upjohn Company Azabicyklicky substituované kondenzované heteroarylsloučeniny
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
ES2276072T3 (es) * 2002-06-10 2007-06-16 Bayer Healthcare Ag Amidas de acidos 2-heteroarilcarboxilicos.
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe
MXPA05001702A (es) * 2002-08-14 2005-04-19 Neurosearch As Derivados de quinuclidina novedosos y su uso.
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
CA2499128C (en) 2002-09-25 2012-07-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
US7238715B2 (en) 2002-12-06 2007-07-03 The Feinstein Institute For Medical Research Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
ATE378048T1 (de) 2002-12-06 2007-11-15 The Feinstein Inst Medical Res Hemmung von entzündungen unter verwendungvon alpha-7-rezeptor verbindenden cholinergen agonisten
PL1697378T3 (pl) 2003-12-22 2008-04-30 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania
WO2005092890A2 (en) 2004-03-25 2005-10-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
DE602005024677D1 (de) 2004-04-22 2010-12-23 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
RU2386633C2 (ru) 2004-05-07 2010-04-20 Мемори Фармасьютиклз Корпорейшн 1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
JP2008525464A (ja) 2004-12-22 2008-07-17 メモリー・ファーマシューティカルズ・コーポレイション α−７ニコチン性受容体リガンド並びにその製造及び使用
FR2884822B1 (fr) * 2005-04-22 2007-06-29 Aventis Pharma Sa Derives de triazines, leur preparation et leur application en therapeutique
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
US8316104B2 (en) 2005-11-15 2012-11-20 California Institute Of Technology Method and apparatus for collaborative system
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
EP2129672B1 (en) * 2007-03-23 2011-05-18 Abbott Laboratories Azaadamantane ester and carbamate derivatives and methods of use thereof
HUE026815T2 (en) 2008-11-19 2016-07-28 Forum Pharmaceuticals Inc Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
TWI519532B (zh) 2010-05-17 2016-02-01 艾維沃製藥公司 （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體
RU2017136693A (ru) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. Способы поддержания, лечения или улучшения когнитивной функции

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5967284A (ja) * 1982-07-13 1984-04-16 サンド・アクチエンゲルシヤフト インドリルカルボン酸ピペリジルエステル誘導体
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
JP4163263B2 (ja) * 1995-04-06 2008-10-08 矢崎総業株式会社 防水コネクタ

Also Published As

Publication number Publication date
JP2002030084A (ja) 2002-01-29

Similar Documents

Publication Publication Date Title
JP2002030084A (ja) １−アザビシクロアルカン化合物およびその医薬用途
TWI417100B (zh) 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
WO2001021615A1 (fr) Dérivés de benzimidazole
JP6968899B2 (ja) 向精神薬およびその使用
JPWO2009022731A1 (ja) Ｐ２ｘ４受容体拮抗剤
KR20060095865A (ko) 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
WO2001066546A1 (en) Spiro compounds, process for preparing the same and use thereof as drugs
JP2001512727A (ja) ５ｈｔ−１受容体のリガンドとしてのニ環式化合物
KR20130122531A (ko) Ｍｇｌｕｒ５ 양성 알로스테릭 조절물로서 치환된 ６­메틸니코틴아미드
JPWO2018021447A1 (ja) ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物
JP5628937B2 (ja) ５−ｈｔ６受容体リガンドとしてのスルホン化合物
DE69736890T2 (de) Kondensierte heterozyklische verbindungen und ihre pharmazeutische anwendung
JPH0747585B2 (ja) イソオキサゾール誘導体
US5834482A (en) Heterocyclic chemistry
SK9398A3 (en) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2- -methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same
CN109689650A (zh) 取代的n-[2-(4-苯氧基哌啶-1-基)-2-(1,3-噻唑-5-基)乙基]苯甲酰胺和n-[2-(4-苄氧基哌啶-1-基)-2-(1,3-噻唑-5-基)乙基]苯甲酰胺衍生物p2x7受体拮抗剂
WO1988003136A1 (fr) Composes de piperazine et leur utilisation medicinale
WO2021149767A1 (ja) ヘテロ環誘導体
RU2175970C2 (ru) Производные пиперидинилметилоксазолидин-2-она, способ их получения и фармацевтическая композиция на их основе
JP2003081978A (ja) スピロ環式化合物およびその医薬用途
JPH10152470A (ja) ピペラジン化合物
KR20030036834A (ko) 5-페닐벤질아민 화합물, 그의 제법 및 그의 합성 중간체
KR20240042472A (ko) 무스카린성 수용체 4 길항제 및 사용 방법
US11447484B2 (en) Cyclic compound having dopamine D3 receptor antagonistic effect
US12319659B2 (en) Selective ligand for dopamine D3 receptor, preparation method therefor, and pharmaceutical application thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070608

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20071102

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100430

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20100430

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100430

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100706

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100902

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101019

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101025

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131029

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees